Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Reck

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Die Pharmazie|December 1, 1989
[Potential cardiotonic agents. 4. Synthesis, cardiovascular activity, molecular and crystal structure of 5-phenyl- and 4-(4-pyridinyl)-substituted 2(1H)-pyridinethiones]V Hagen, A Rumler, G Reck, et al.
Helvetica Medica Acta|May 1, 1974
[Proceedings: Regulation of aldosterone secretion in patients without kidneys]W Vetter, K Záruba, H Armbruster, et al.
Journal of Molecular Graphics|September 1, 1989
Molecular mechanics and X-ray crystal structure investigations on conformations of 11 beta substituted 4,9-dien-3-one steroidsM Bohl, G Schubert, K Ponsold, et al.
Clinical Endocrinology|October 1, 1974
Control of plasma aldosterone in supine anephric manW Vetter, K Záruba, H Armbruster, et al.
Schweizerische Medizinische Wochenschrift|December 7, 1974
[Activity of plasma renin and plasma aldosterone in terminal renal failure]W Vetter, K Záruba, H Armbruster, et al.
Archives of Gynecology|January 1, 1980
Plasma levels of FSH and LH in patients with gonadal dysgenesis during sequential estrogen and progestogen therapyM Breckwoldt, H Roll, H P Zahradnik, et al.
Human Genetics|January 1, 1980
A new case of Y to X translocation in a femaleT Hecht, H J Cooke, M Cerrillo, et al.
Science (New York, N.Y.)|March 10, 1995
A "Double-Diamond Superlattice" Built Up of Cd17S4(SCH2CH2OH)26 ClustersT Vossmeyer, G Reck, L Katsikas, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1974
[Daily rhythm of plasma renin and aldosterone following kidney allotransplantation]H Armbruster, W Vetter, G Uhlschmid, et al.
Die Pharmazie|March 1, 1988
[Crystal modifications of 3-cyan-6-methyl-5-(pyrid-4-yl)-1,2-dihydropyrid-2-one (milrinone)]E Klauschenz, V Hagen, B Gentsch, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Die Pharmazie|December 1, 1989
[Potential cardiotonic agents. 4. Synthesis, cardiovascular activity, molecular and crystal structure of 5-phenyl- and 4-(4-pyridinyl)-substituted 2(1H)-pyridinethiones]V Hagen, A Rumler, G Reck, et al.
Helvetica Medica Acta|May 1, 1974
[Proceedings: Regulation of aldosterone secretion in patients without kidneys]W Vetter, K Záruba, H Armbruster, et al.
Journal of Molecular Graphics|September 1, 1989
Molecular mechanics and X-ray crystal structure investigations on conformations of 11 beta substituted 4,9-dien-3-one steroidsM Bohl, G Schubert, K Ponsold, et al.
Clinical Endocrinology|October 1, 1974
Control of plasma aldosterone in supine anephric manW Vetter, K Záruba, H Armbruster, et al.
Schweizerische Medizinische Wochenschrift|December 7, 1974
[Activity of plasma renin and plasma aldosterone in terminal renal failure]W Vetter, K Záruba, H Armbruster, et al.
Archives of Gynecology|January 1, 1980
Plasma levels of FSH and LH in patients with gonadal dysgenesis during sequential estrogen and progestogen therapyM Breckwoldt, H Roll, H P Zahradnik, et al.
Human Genetics|January 1, 1980
A new case of Y to X translocation in a femaleT Hecht, H J Cooke, M Cerrillo, et al.
Science (New York, N.Y.)|March 10, 1995
A "Double-Diamond Superlattice" Built Up of Cd17S4(SCH2CH2OH)26 ClustersT Vossmeyer, G Reck, L Katsikas, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1974
[Daily rhythm of plasma renin and aldosterone following kidney allotransplantation]H Armbruster, W Vetter, G Uhlschmid, et al.
Die Pharmazie|March 1, 1988
[Crystal modifications of 3-cyan-6-methyl-5-(pyrid-4-yl)-1,2-dihydropyrid-2-one (milrinone)]E Klauschenz, V Hagen, B Gentsch, et al.
Pageof 6